Eva Mistry News Today

Local researchers have just launched a new study, which could provide a new treatment to help in stroke recovery.

SISTER study to test efficacy of new treatment for acute ischemic stroke

The University of Cincinnati and UC Health have been renewed as the National Coordinating Center of the National Institutes of Health (NIH) StrokeNet, which is the primary infrastructure for multicenter trials of stroke funded by NIH and the pipeline for new potential treatments for adults and children with stroke and those at risk for stroke.

Using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe.

Lowering blood pressure after clot removal may not be safe, and should be individualized, according to findings of the BEST II Trial presented during the American Stroke Association International Stroke Conference.

Using blood pressure medications to lower the top number of blood pressure reading (systolic blood pressure) may not be safe or effective among people who have an acute ischemic stroke and undergo a successful mechanical clot removal — endovascular therapy, according to a phase-2 late-breaking clinical trial presented today at the American Stroke Association's International Stroke Conference 2023.

There doesn’t appear to be a reason to artificially lower BP in this scenario, unless the systolic reading climbs above 180 mm Hg.

When conducting clinical research, investigators aim to control as many variables as possible so it is easier to examine the effectiveness of new treatments.

Aiming for a systolic BP below 120 mm Hg instead of 140-180 mm Hg worsened functional outcomes at 90 days.

UC’s Mistry leads BEST-II clinical trial, attends leadership forum